Business
Quantum eMotion's Cybersecurity Endeavors Boosted by Greybox Solutions Digital Therapeutics Platform Breakthrough Results in Heart Failure Study
Boehringer Ingelheim (Canada) Ltd, a significant sponsor Montreal, Quebec--(Newsfile Corp. - Nov...
About this update from Quantum Emotion Corp.
[{"type":"text","content":"Quantum eMotion's Cybersecurity Endeavors Boosted by Greybox Solutions Digital Therapeutics Platform Breakthrough Results in Heart Failure StudyBoehringer Ingelheim (Canada) Ltd, a significant sponsorMontreal, Quebec--(Newsfile Corp. - November 21, 2023) - Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) (\"QeM\" or the \"Company\") a trailblazer in classical and quantum cybersecurity, is delighted to share a significant stride in its path to commercialization.In a recent clinical study, Greybox Solutions Inc., a key partner of Quantum eMotion in its commercial strategy in digital healthcare, showcased remarkable success with its remote patient monitoring and digital therapeutics platform (DTx) in treating heart failure outpatients. The study revealed a significant reduction in emergency room visits and/or hospitalizations and a 23% decrease in healthcare costs, as highlighted in preliminary results presented at the American Heart Association's Scientific Sessions held November 11-13, 2023, in Philadelphia, Pennsylvania.Developed in collaboration with the Centre hospitalier de l'Université de Montréal (CHUM), Boehringer Ingelheim (Canada) Ltd., and MEDTEQ+, this DTx study is providing significant insights in addressing heart failure utilizing Takecare, a technological platform including a self-care application for patients, a clinical dashboard enabling remote-monitoring by the team, a DTx module providing automated medication suggestions to the treatment team and finally, educational modules for patients - a crucial development in an era where digital health solutions for this disease are gaining traction without conclusive evidence of their impact on public healthcare systems in North America. With 750,000 Canadians living with heart failure and over 100,000 new diagnoses annually, this condition is a leading cause of hospitalization in Canada. Projections indicate that by 2030, associated healthcare costs in the country will surge to $2.8 billion annually.Francis Bellido, CEO of Quantum eMotion, expressed excitement about Greybox's milestone and its positive implications for the commercialization of the Sentry-Q cybersecurity platform. He emphasized the critical role of robust cybersecurity in safeguarding sensitive patient data amid escalating data breaches. Bellido commended Greybox's formidable partners in the st...